TetraLogic Announces Termination of Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
TetraLogic Pharma (TLOG) to Resume Trading at 2:30
May 6, 2015 2:28 PM EDTTetraLogic Pharma (NASDAQ: TLOG) to Resume Trading at 2:30
... MoreTetraLogic Pharma (TLOG) Terminates Common Stock Offering
May 6, 2015 2:26 PM EDTTetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced termination of the underwriting agreement for and cancellation of its previously announced underwritten public offering of 6.25 million... More
Tetralogic (TLOG) PT Cut to $7 at Needham & Company After Halting Study; Maintains 'Buy'
May 6, 2015 2:08 PM EDTNeedham & Company analyst Chad Messer cut his price target on Tetralogic Pharmaceuticals (NASDAQ: TLOG) to $7.00 (from $10.00) after the comapny announced that it will temporarily halt enrollment multiple ascending dose chronic hepatitis B (HBV) trial of birinapant. However, the firm maintained a Buy... More
